[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335348-105":59,"doc-detail-335348-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","local-excision-versus-total-mesorectal-excision-for-rectal-cancer-patients-with-clinical-complete-or-near-complete-response-after-neoadjuvant-chemoradiotherapy","Local excision versus total mesorectal excision for rectal cancer patients with clinical complete or near-complete response after neoadjuvant chemoradiotherapy","","Local excision is an effective strategy for managing rectal cancer showing substantial regression after neoadjuvant chemoradiotherapy. This retrospective cohort study compared outcomes between local excision and total mesorectal excision in patients achieving clinical complete or near-complete response following neoadjuvant chemoradiotherapy. Data from 180 patients over 12 years at a single institution assessed short-term, oncological, and functional outcomes, showing improved perioperative course and function with oncologic trade-offs.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/local-excision-versus-total-mesorectal-excision-for-rectal-cancer-patients-with-clinical-complete-or-near-complete-response-after-neoadjuvant-chemoradiotherapy/335348/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/local-excision-versus-total-mesorectal-excision-for-rectal-cancer-patients-with-clinical-complete-or-near-complete-response-after-neoadjuvant-chemoradiotherapy/335348.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What patient group was evaluated in this study?","Question",{"text":112,"@type":113},"Rectal cancer patients who achieved either clinical complete response or clinical near-complete response after neoadjuvant chemoradiotherapy, then underwent surgery.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did local excision compare with total mesorectal excision in short-term outcomes?",{"text":117,"@type":113},"The local excision group had significantly shorter operative time, less blood loss, and shorter hospital stay (p \u003C 0.001).",{"name":119,"@type":110,"acceptedAnswer":120},"Did oncological outcomes differ between the two surgical approaches?",{"text":121,"@type":113},"Local excision showed a significantly higher 3-year local recurrence rate (p = 0.017) but lower 3-year distant metastasis and disease-free survival rates were not statistically significant overall.",{"name":123,"@type":110,"acceptedAnswer":124},"What conclusion did the authors reach about surgical selection?",{"text":125,"@type":113},"Patients with clinical complete or near-complete response after neoadjuvant chemoradiotherapy are suitable candidates for local excision, with superior short-term and functional outcomes and no compromise in overall oncological outcomes as concluded by the study.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335348,1790603804,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","International Journal of Colorectal Disease (2024) 39:157  \n[https://doi.org/10.1007/s00384-024-04720-w](https://doi.org/10.1007/s00384-024-04720-w)  \nLocal excision versus total mesorectal excision for rectal cancer patients with clinical complete or near‑complete response after neoadjuvant chemoradiotherapy  \nLu Jin1 · Kuo Zheng2 · Yonggang Hong1 · Enda Yu1 · Liqiang Hao1 · Wei Zhang1  \nAccepted: 12 September 2024 / Published online: 8 October 2024 © The Author(s) 2024  \nAbstract  \nPurpose Local excision is an effective approach for managing rectal cancer exhibiting substantial regression after neoadjuvant chemoradiotherapy. The purpose of this study is to compare the outcomes between local excision and total mesorectal excision in rectal cancer patients achieving clinical complete or near-complete response after neoadjuvant chemoradiotherapy. Methods This is a retrospective cohort study that includes a consecutive series of rectal cancer patients who responded well to neoadjuvant chemoradiotherapy followed by surgery. A total of 180 rectal cancer patients at a single institution during a 12-year period are included. The main outcomes include short-term outcomes, oncological outcomes, and functional outcomes between the two groups.  \nResults A total of 180 patients were included in the study. Sixty-one (33.9%) received local excision and 119 (66.1%) received total mesorectal excision. The baseline characteristics were generally balanced between the two groups. The local excision group demonstrated a significantly shorter operative time, less blood loss, and shorter hospital stay (p \u003C 0.001). 3-year overall survival rates were 97.5%(95% CI, 0.93–1.00) and 95.5%(95% CI, 0.91–1.00) between the two groups (p = 0.38) . The local excision group exhibited significantly higher 3-year local recurrence rates 15.7%(95% CI, 0.74–0.97) vs 4.2%(95% CI, 0.92–1.00) (p = 0.017), yet lower 3-year distant metastasis rates 9.6%(95% CI, 0.82–1.00) vs 12.6%(95% CI, 0.81–0.94)(p = 0.33) and lower 3-year disease-free survival rates 76.8%(95% CI, 0.64–0.92) vs 84.7%(95% CI, 0.78–0.92) (p = 0.56) comparing with the total mesorectal excision group. The local excision group demonstrated significantly better functional outcomes compared with the total mesorectal excision group (p \u003C 0.001) .  \nConclusion Patients who achieve either clinical complete or near-complete response after neoadjuvant chemoradiotherapy are suitable candidates for local excision. The local excision group demonstrated superior short-term and functional outcomes, and the oncological outcomes were not compromised.  \nKeywords Rectal cancer · Neoadjuvant chemoradiotherapy · Clinical complete response · Clinical near-complete response · Local excision  \nLu Jin and Kuo Zheng contributed equally to this work.  \n* Liqiang Hao [hao_liqiang@139.com](hao_liqiang@139.com)  \n* Wei Zhang [weizhang2000cn@163.com](weizhang2000cn@163.com)  \n1 Department of Anorectal Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China  \n2 Department of Critical Care Medicine, Jinling Hospital of Medical School of Nanjing University, Nanjing 210016, Jiangsu, China  \nIntroduction  \nColorectal cancer is one of the most common digestive cancers in the world. Reportedly, in 2020, its incidence ranks third (10%), its mortality rate ranks second, and both of them show an increasing trend [1] .  \nThe current standard of care for locally advanced rectal cancers (LARC) is neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) and adjuvant chemotherapy [2]. Although TME can improve the prognosis of patients, its mortality rate is 2–3% and it is closely associated with urinary, sexual, and bowel dysfunction [3–6]. Along with changes in the habits of defecation, about 50–90% of  \npatients will also present low anterior resection syndrome (LARS) [7] . In addition, because the locations of most rectal cancers are low, patients usually need to receive temporary or per","cbCaiqm91hN5PtI4","https://ap.wps.com/l/cbCaiqm91hN5PtI4","pdf",1061102,11,"English","# Abstract\n# Purpose\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What patient group was evaluated in this study?\",\"answer\":\"Rectal cancer patients who achieved either clinical complete response or clinical near-complete response after neoadjuvant chemoradiotherapy, then underwent surgery.\"},{\"question\":\"How did local excision compare with total mesorectal excision in short-term outcomes?\",\"answer\":\"The local excision group had significantly shorter operative time, less blood loss, and shorter hospital stay (p \\u003c 0.001).\"},{\"question\":\"Did oncological outcomes differ between the two surgical approaches?\",\"answer\":\"Local excision showed a significantly higher 3-year local recurrence rate (p = 0.017) but lower 3-year distant metastasis and disease-free survival rates were not statistically significant overall.\"},{\"question\":\"What conclusion did the authors reach about surgical selection?\",\"answer\":\"Patients with clinical complete or near-complete response after neoadjuvant chemoradiotherapy are suitable candidates for local excision, with superior short-term and functional outcomes and no compromise in overall oncological outcomes as concluded by the study.\"}]","Local excision versus total mesorectal excision for rectal cancer patients with clinical complete or near-complete response after neoadjuvant chemoradiotherapy | PDF",1790010651,28]